Back to search

Article

Nephrotic Syndrome-Associated Hypercoagulopathy is Alleviated by Nuclear Receptor Agonist Therapy with both Pioglitazone and Glucocorticoids

2020-01-07

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Thrombosis is a potentially life-threatening nephrotic syndrome (NS) complication. We have previously demonstrated that hypercoagulopathy is proportional to NS severity in rat models and that pioglitazone (Pio) reduces proteinuria both independently and in combination with methylprednisolone (MP), a glucocorticoid (GC). However, the effect of these treatments on NS-associate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9510089b-4f9f-528b-a636-7891623b05d1
DOI
10.1101/2020.01.07.897751
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nephrotic Syndrome-Associated Hypercoagulopathy is Alleviated by Nuclear Receptor Agonist Therapy with both Pioglitazone and GlucocorticoidsDOI 10.1101/2020.01.07.897751
Select a neighboring publication to make it the new centre.